Mycobacterium vaccae is a soil saprophyte which exerts anti-allergic properties. There are data that mechanism of action of M. vaccae when used in the treatment of human and animal allergic diseases is associated with Th1-phenotype switch. Here we studied the properties of sonicated M. vaccae lysate in co-cultures of dendritic cells and CD4+T cells. M. vaccae lysate stimulated IL-10 synthesis in co-cultures and CD86 expression in dendritic cells, being more potent than heat-killed M. vaccae. The reported clinical data and the mechanism of action of M. vaccae lysate suggest that its use is a feasible option for the primary prevention of allergic diseases, in particular atopic dermatitis.
Similar content being viewed by others
References
Arkwright PD, David TJ. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br. J. Dermatol. 2003;149(5):1029-1034.
Bazzi S, El-Darzi E, McDowell T, Modjtahedi H, Mudan S, Achkar M, Akle C, Kadara H, Bahr GM. Defining genome-wide expression and phenotypic contextual cues in macrophages generated by granulocyte/macrophage colony-stimulating factor, macrophage colony-stimulating factor, and heat-killed mycobacteria. Front. Immunol. 2017;8:1253. https://doi.org/10.3389/fimmu.2017.01253
Bazzi S, Modjtahedi H, Mudan S, Achkar M, Akle C, Bahr GM. Immunomodulatory effects of heat-killed Mycobacterium obuense on human blood dendritic cells. Innate Immun. 2017;23(7):592-605.
Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Aldridge CR, Leech SN, Morgan C, Clark SM, Ogilvie S, Chopra S, Harper JI, Smith CH, Rook GA, Friedmann PS. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Clin. Exp. Allergy. 2006;36(9):1115-1121.
Davies MG, Symons C, Shaw S, Kaminski ER. An open study to assess the efficacy clinically and immunologically of M. vaccae vaccine in patients with atopic dermatitis. J. Dermatolog. Treat. 2006;17(2):74-77.
Dunstan JA, Brothers S, Bauer J, Hodder M, Jaksic MM, Asher MI, Prescott SL. The effects of Mycobacteria vaccae derivative on allergen-specific responses in children with atopic dermatitis. Clin. Exp. Immunol. 2011;164(3):321-329.
EMA/502527/2019. Bacterial lysates-containing medicinal products indicated for respiratory conditions. URL: https://www.ema.europa.eu/en/documents/referral/bacterial-lysate-medicines-article-31-referral-chmp-assessment-report_en.pdf
Grönroos M, Parajuli A, Laitinen OH. Short-term direct contact with soil and plant materials leads to an immediate increase in diversity of skin microbiota. MicrobiologyOpen. 2019;8(3):e00645. https://doi.org/10.1002/mbo3.645
Hassell JE Jr, Fox JH, Arnold MR, Siebler PH, Lieb MW, Schmidt D, Spratt EJ, Smith TM, Nguyen KT, Gates CA, Holmes KS, Schnabel KS, Loupy KM, Erber M, Lowry CA. Treatment with a heat-killed preparation of Mycobacterium vaccae after fear conditioning enhances fear extinction in the fear-potentiated startle paradigm. Brain Behav. Immun. 2019;81:151-160.
Le Bert N, Chain BM, Rook G, Noursadeghi M. DC Priming by M. vaccae inhibits Th2 responses in contrast to specific TLR2 priming and is associated with selective activation of the CREB pathway. PLoS One. 2011;6(4):e18346. https://doi.org/10.1371/journal.pone.0018346
Myles IA, Earland NJ, Anderson ED, Moore IN, Kieh MD, Williams KW, Saleem A, Fontecilla NM, Welch PA, Darnell DA, Barnhart LA, Sun AA, Uzel G, Datta SK. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 2018;3(9):120608. https://doi.org/10.1172/jci.insight.120608
Nesmiyanov P, Gutov M, Strygin A, Tolkachev B, Morkovin E, Dotsenko A. M. vaccae-based formulation for the primary prevention of atopic dermatitis. Allergy 2018;73, S105:107.
Schülke S. Induction of Interleukin-10 producing dendritic cells as a tool to suppress allergen-specific T helper 2 responses. Front. Immunol. 2018;9:455. https://doi.org/10.3389/fimmu.2018.00455
Súkeníková L, Černý V, Novotná O, Petrásková P, Boráková K, Kolářová L, Prokešová L, Hrdý J. Different capacity of in vitro generated myeloid dendritic cells of newborns of healthy and allergic mothers to respond to probiotic strain E. coli O83:K24:H31. Immunol. Lett. 2017;189:82-89.
Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet L.R, Kemeny DM, Bowen G, Rook G, Walker C. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 2002;8(6):625-629.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 170, No. 8, pp. 196-200, August, 2020
Rights and permissions
About this article
Cite this article
Strygin, A.V., Nesmiyanov, P.P., Petrov, V.I. et al. Mycobacterium vaccae Lysate Induces Anti-Allergic Immune Response In Vitro. Bull Exp Biol Med 170, 226–229 (2020). https://doi.org/10.1007/s10517-020-05039-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-020-05039-6